If you enjoy this content, please share it with a colleague
Median Technologies
RELATED CONTENT
February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier ...
July 12, 2022 — Median Technologies (ALMDT) announced that the company will be participating in the 2022 European ...
May 31, 2022 — Median Technologies announces that the company is expanding its portfolio of services with Imaging Lab, a ...
May 13, 2022 — Median Technologies announced that the company has received feedback from the United States Food and Drug ...
March 3, 2022 — Median Technologies announced that the company has filed a 513(g) submission on Feb. 17, 2022, to the ...
February 10, 2021 — Median Technologies announced the company has signed a research collaboration agreement with the Uni ...
Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City, China. Within the frame of the agreement, Median's MediScan image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People's Hospital in Xingtai City. These programs are critically important to improving the health of the people of Xingtai City since the incidence of and mortality associated with lung cancer have increased dramatically in China and become a nationwide public health issue, giving rise to an increased burden on patients, healthcare professionals and society.
October 20, 2017 — Median Technologies announced that it will participate in The Liver Meeting, the annual meeting of ...
September 7, 2017 — Median Technologies announced that it will lead a scientific and medical roundtable on Sept. 7 in ...
Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.